Market Research Logo

Algeria Pharmaceuticals and Healthcare Report Q2 2016

Algeria Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Despite a slowdown in the Algerian economy due to low oil prices, the country'spharmaceutical and healthcare markets are expected to sustain their positive growth trajectory over amulti-quarter horizon. The health sector expansion will be supported by long-term drivers such as growingdemand for healthcare and treatment, healthcare system modernisation and sustained foreign investment indomestic drug manufacturing. Although we expect foreign investors to continue benefittingfrom government incentives aimed at boosting domestic pharmaceutical production and technologytransfer, operating challenges will continue weigh on the market's full potential.

Headline Expenditure Projections

Pharmaceuticals: DZD411.62bn (USD4.12bn) in 2015 to DZD451.90bn (USD4.13bn) in 2016; +9.8%in local currency and +0.3% in US dollar terms. Forecast in line with last quarter.

Healthcare: DZD1,113.59bn (USD11.13bn) in 2015 to DZD1,204.64bn (USD11.00bn) in 2016; +8.2%in local currency and -1.2% in US dollar terms. Forecast revised upwards in local currency terms anddownwards in US dollar terms from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Algeria 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Algeria 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Algeria 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Algeria 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Algeria 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Algeria 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Algeria 2014-2020)
Industry Risk/Reward Index
Middle East and Africa Risk/Reward Index - Q2 2016
Algeria Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail
Company Profile
GlaxoSmithKline
Groupe Saidal
Merck & Co
Novartis
Pfizer
Sanofi
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Algeria 1990-2025)
Table: Key Population Ratios (Algeria 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Algeria 1990-2025)
Table: Population By Age Group (Algeria 1990-2025)
Table: Population By Age Group % (Algeria 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report